BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 10687340)

  • 1. Morphine with dextromethorphan: conversion from other opioid analgesics.
    Chevlen E
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S42-9. PubMed ID: 10687339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients.
    Katz NP
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S37-41. PubMed ID: 10687338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance.
    Galer BS; Lee D; Ma T; Nagle B; Schlagheck TG
    Pain; 2005 Jun; 115(3):284-295. PubMed ID: 15911155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MorphiDex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain.
    Caruso FS
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S31-6. PubMed ID: 10687337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse potential of morphine/dextromethorphan combinations.
    Jasinski DR
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S26-30. PubMed ID: 10687336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine/dextromethorphan--Endo: E 3231, Morphidex.
    Drugs R D; 2003; 4(1):55-6. PubMed ID: 12568639
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
    Patatanian E; Casselman J
    Consult Pharm; 2014 Apr; 29(4):264-9. PubMed ID: 24704895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of dual-opioid therapy in acute pain.
    Webster L
    Pain Med; 2012 Mar; 13 Suppl 1():S12-20. PubMed ID: 22420602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature.
    Tassinari D; Sartori S; Tamburini E; Scarpi E; Raffaeli W; Tombesi P; Maltoni M
    J Palliat Med; 2008 Apr; 11(3):492-501. PubMed ID: 18363493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of MorphiDex.
    Goldblum R
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S50-6. PubMed ID: 10687340
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.